BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphoma is among the most common forms of extranodal lymphomas, but little is known about subcutaneous involvement in patients with non-primary cutaneous marginal zone lymphomas. DESIGN AND METHODS: Patients with MALT lymphoma diagnosed and treated at our institution between 1999 and 2010 were analyzed for subcutaneous deposits from MALT lymphoma diagnosed in another organ. Histological, clinical and genetic findings were assessed. RESULTS: Among 216 patients with MALT lymphoma, 12 had subcutaneous deposits from MALT lymphoma (5.5%). In two patients, these lesions were present at diagnosis, while they constituted the site of relapse at an interval between 5 to 144 months in the remaining cases. Interestingly, nine of the 12 patients with subcutaneous deposits had originally been diagnosed with MALT lymphoma of the ocular adnexa (total number=51; 20%), and the other three had MALT lymphoma in the breast (total number=5; 60%). None of the patients with gastric (n=86), salivary gland (n=32) or pulmonary (n=19) MALT lymphomas had subcutaneous involvement during a median follow-up time of 87 months (range; 4 to 119 months). CONCLUSIONS: Our data show that subcutaneous MALT lymphoma involvement is a rare event in patients with prior non-cutaneous extranodal marginal zone lymphoma. However, it seems to be almost exclusively associated with MALT lymphoma of the ocular adnexa and the breast, suggesting as yet undefined interactions between potentially embryonically related organ systems.
BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphoma is among the most common forms of extranodal lymphomas, but little is known about subcutaneous involvement in patients with non-primary cutaneous marginal zone lymphomas. DESIGN AND METHODS: Patients with MALT lymphoma diagnosed and treated at our institution between 1999 and 2010 were analyzed for subcutaneous deposits from MALT lymphoma diagnosed in another organ. Histological, clinical and genetic findings were assessed. RESULTS: Among 216 patients with MALT lymphoma, 12 had subcutaneous deposits from MALT lymphoma (5.5%). In two patients, these lesions were present at diagnosis, while they constituted the site of relapse at an interval between 5 to 144 months in the remaining cases. Interestingly, nine of the 12 patients with subcutaneous deposits had originally been diagnosed with MALT lymphoma of the ocular adnexa (total number=51; 20%), and the other three had MALT lymphoma in the breast (total number=5; 60%). None of the patients with gastric (n=86), salivary gland (n=32) or pulmonary (n=19) MALT lymphomas had subcutaneous involvement during a median follow-up time of 87 months (range; 4 to 119 months). CONCLUSIONS: Our data show that subcutaneous MALT lymphoma involvement is a rare event in patients with prior non-cutaneous extranodal marginal zone lymphoma. However, it seems to be almost exclusively associated with MALT lymphoma of the ocular adnexa and the breast, suggesting as yet undefined interactions between potentially embryonically related organ systems.
Authors: M Troch; S Woehrer; B Streubel; M Weissel; M Hoffmann; L Müllauer; A Chott; M Raderer Journal: Ann Oncol Date: 2008-03-11 Impact factor: 32.976
Authors: Lucie Peduto; Sophie Dulauroy; Matthias Lochner; Gerald F Späth; Miguel A Morales; Ana Cumano; Gérard Eberl Journal: J Immunol Date: 2009-05-01 Impact factor: 5.422
Authors: A J M Ferreri; G P Dognini; M Ponzoni; L Pecciarini; M G Cangi; G Santambrogio; A G Resti; C De Conciliis; S Magnino; E Pasini; N Vicari; R Dolcetti; C Doglioni Journal: Ann Oncol Date: 2007-12-10 Impact factor: 32.976
Authors: Thomas Wündisch; Christian Thiede; Andrea Morgner; Astrid Dempfle; Annette Günther; Hongxiang Liu; Hongtao Ye; Ming-Qing Du; Theo D Kim; Ekkehard Bayerdörffer; Manfred Stolte; Andreas Neubauer Journal: J Clin Oncol Date: 2005-10-03 Impact factor: 44.544
Authors: Tae Min Kim; Ki Hwan Kim; Min Joung Lee; Yoon Kyung Jeon; Se-Hoon Lee; Dong-Wan Kim; Chul Woo Kim; Il Han Kim; Sang In Khwarg; Dae Seog Heo Journal: Cancer Sci Date: 2010-01-19 Impact factor: 6.716
Authors: Markus Raderer; Stefan Wöhrer; Berthold Streubel; Marlene Troch; Karl Turetschek; Ulrich Jäger; Cathrin Skrabs; Alexander Gaiger; Johannes Drach; Andreas Puespoek; Michael Formanek; Martha Hoffmann; Wolfgang Hauff; Andreas Chott Journal: J Clin Oncol Date: 2006-06-12 Impact factor: 44.544
Authors: Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer Journal: Blood Date: 2005-02-03 Impact factor: 22.113
Authors: M Paulli; L Arcaini; M Lucioni; E Boveri; D Capello; F Passamonti; M Merli; S Rattotti; D Rossi; R Riboni; E Berti; U Magrini; R Bruno; G Gaidano; M Lazzarino Journal: Ann Oncol Date: 2009-10-25 Impact factor: 32.976
Authors: S Wöhrer; M Troch; B Streubel; J Zwerina; C Skrabs; M Formanek; W Hauff; M Hoffmann; L Müllauer; A Chott; M Raderer Journal: Leukemia Date: 2007-06-07 Impact factor: 11.528
Authors: A Stathis; C Chini; F Bertoni; I Proserpio; C Capella; L Mazzucchelli; E Pedrinis; F Cavalli; G Pinotti; E Zucca Journal: Ann Oncol Date: 2009-02-04 Impact factor: 32.976
Authors: Cecile D Moliva Anendaga; Madhavi Raghu; Jaime L Szarmach; Seema Bakhru; Francis T Flaherty; Gilda Boroumand Journal: Radiol Case Rep Date: 2022-08-20